[Cost of cancer in France: pharmaceutical expenditure as part of global patients' care].

@article{Zambrowski2008CostOC,
  title={[Cost of cancer in France: pharmaceutical expenditure as part of global patients' care].},
  author={J J Zambrowski},
  journal={Bulletin du cancer},
  year={2008},
  volume={95 5},
  pages={535-41}
}
The INCa, as well as the French National Health Insurance recently published, and for the first time, important reports making it possible to take stock of the cost of care for the patients treated for a cancer or a malignant hemopathy, and in particular on the pharmaceutical expenditure related to cancer. The number of people with full medical coverage ("ALD") for cancer increased by 62% in 10 years, and exceeds 1.25 million people today. The corresponding expenditure is close to 14 billions… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.

Added value of molecular targeted agents in oncology.

Annals of oncology : official journal of the European Society for Medical Oncology • 2011

Similar Papers

Loading similar papers…